The present disclosure is related to infusion pumps and, more particularly, to a lockbox for housing an ambulatory infusion pump and a fluid source containing an infusate being administered via the ambulatory infusion pump.
Infusion pumps deliver controlled doses of fluids such as medications, analgesics, and nutrition to patients. Infusion pumps are particularly well suited to delivering controlled doses of fluids over long periods of time, e.g., several hours or days. While many infusion pumps are designed for bedside use, there are ambulatory versions available. Ambulatory infusion pumps allow a patient to move around while the infusion pump is in use.
Syringe pumps and peristaltic pumps are two conventional types of infusion pumps. A syringe pump depresses a cylinder within a syringe to deliver fluid from the syringe to a patient. A peristaltic pump acts on a tube to control the rate of fluid flow through the tube from a bottle or bag of fluid to a patient. Precise delivery of fluids is desirable to optimize treatment of a patient as there are many fluids where small variations can be critical.
To limit access to medications by unauthorized personnel, fluid medications administered by infusion pumps may be stored in an intravenous (IV) fluid hanger housing. Such housings may be mounted on an IV pole and used bedside in a hospital setting. While such housings provide safe operation without unauthorized access to the IV fluid medications, such housings do not accommodate ambulatory infusion pumps while providing access to the user interfaces of the ambulatory infusion pumps for programming by medical personnel while simultaneously preventing access to the fluid medications. Moreover, such housings tend to become unbalanced once the IV fluid is disposed in the housing, thus causing the housing to slide around the IV pole during access by medical personnel and adversely affecting operation of the infusion pump.
Examples described herein are directed to a lockbox that securely stores an ambulatory infusion pump and a fluid source (e.g., a fluid bag) containing an infusate for delivery via the ambulatory pump. The infusate may be a controlled substance (e.g., an opioid). The lockbox is designed such that the infusate (e.g., from a bag, syringe, or a bottle) can be securely stored and dispensed without impacting the operation of the ambulatory infusion pump.
In sample configurations, the lockbox is configured to securely mount an ambulatory infusion pump and a fluid bag containing an infusate to a pole to securely store and dispense the infusate without impacting operation of the ambulatory infusion pump. A cradle is adapted to receive the ambulatory infusion pump. The lockbox is mounted to a pole by inserting screws from an interior of the lockbox housing through holes in the cradle and in the lockbox housing to terminate in a lockable pole clamp. The lockbox housing has an L-shaped configuration with a first portion shaped and sized for the fluid bag and a second portion sized and shaped to accommodate the ambulatory infusion pump and to provide access to the ambulatory infusion pump for programming. The L-shaped configuration distributes weight evenly when the lockbox is mounted on the pole and provides increased stability of the mounting pole and lockbox housing.
In sample configurations, a lockbox is adapted to house an ambulatory infusion pump and a fluid bag containing an infusate that is provided to the ambulatory infusion pump via tubing. The lockbox includes an L-shaped housing including a first portion adapted to securely store the fluid bag and a second portion adapted to securely store the ambulatory infusion pump. The housing includes a front cover including a front opening that provides access to a display of the ambulatory infusion pump when mounted in the cradle without providing access to the fluid bag or the tubing. The housing also may have a bottom opening that provides access to connection ports on a bottom of the ambulatory infusion pump. A cradle is provided in the second portion that is adapted to mount the ambulatory infusion pump, and a bag support is provided in the first portion to mount the fluid bag. A lockable pole clamp is adapted to mount the housing to a pole by terminating screws that are inserted from an interior of the housing through first mounting holes in the housing and second mounting holes in the cradle. The first mounting holes in the housing and the second mounting holes in the cradle may be selectively oriented horizontally or vertically for termination in the lockable pole clamp. The lockable pole clamp may include a screw that is rotated and locked to secure the lockable pole clamp and the housing to the pole.
The first portion and the second portion are sized and shaped to distribute weight evenly when the housing is mounted to the pole, the fluid bag is mounted on the bag support, and the ambulatory infusion pump is mounted on the cradle. A lock locks the front cover to the first portion and the second portion once the ambulatory infusion pump has been mounted in the cradle and the fluid bag has been mounted on the bag support.
The drawing figures depict multiple views of one or more implementations, by way of example only, not by way of limitations. In the figures, like reference numerals refer to the same or similar elements. The same numeral is used to represent the same or similar element across the multiple views. If multiple elements of the same or similar type are present, a letter may be used to distinguish between the multiple elements. When the multiple elements are referred to collectively or a non-specific one of the multiple elements is being referenced, the letter designation may be dropped.
In the following detailed description, numerous specific details are set forth by way of examples in order to provide a thorough understanding of the relevant teachings. However, it should be apparent to those skilled in the art that the present teachings may be practiced without such details. In other instances, well-known methods, procedures, components, and circuitry have been described at a relatively high-level, without detail, in order to avoid unnecessarily obscuring aspects of the present teachings. Moreover, while described with respect to an ambulatory peristaltic infusion pump, it will be appreciated by those skilled in the art that the lockbox described herein may be used with a variety of other pump types.
The ambulatory peristaltic infusion pump 100 includes a user interface 122 for interacting with the ambulatory peristaltic infusion pump 100. The illustrated user interface 122 includes a display 124 (which may be a touchscreen) and buttons 126. A user controls the operation of the ambulatory peristaltic infusion pump 100 via the user interface 122. The ambulatory peristaltic infusion pump 100 additionally includes a housing 128 for containing and supporting the components of the ambulatory peristaltic infusion pump 100 such as the peristaltic pump 106, electronics, power supplies, and the like.
The free flow prevention clamp 110 includes a first elongate section 112a, a second elongate section 112b, and a clamping section 112c. The housing 130 of the cassette 102 supports the free flow prevention clamp 110. The clamping section 112c is positioned within the cassette geometry such that, when the cassette 102 is received within the receptacle 104 of the ambulatory peristaltic infusion pump 100, the clamping section 112c extends across the channel receiving the tube 108. The housing 130 of the cassette 102 may be rigid plastic or other material capable of supporting the tube 108 and free flow prevention clamp 110.
The ambulatory peristaltic infusion pump 100 also includes a pair of arc cams 114a and 114b (
The cassette 102 also includes a first cutout 118a in a sidewall 132 of the cassette 102 and a second cutout 118b in an opposite sidewall 134 of the cassette 102. Additionally, the cassette 102 includes a touch pad 120 positioned on the first elongate section 112a adjacent a mid-point of the first elongate section 112a and the first cutout 118a. The touch pad 120 and cutout 118a together facilitate engagement of the first elongate section 112a by a finger of an operator in order to manually lift the clamping section 112c to allow fluid flow through the tube 108 (e.g., for priming the cassette 102) when the cassette 102 is not received within the receptacle 104 of the ambulatory peristaltic infusion pump 100. The touch pad 120 may be a press fit piece of rigid plastic. Although the touch pad 120 is illustrated as only on the first elongate section 112a, the touch pad 120 also may be provided on the second elongate section 112b.
The ambulatory infusion pump 100 further includes connection ports 136 that provide electronic access for control and for powering the ambulatory infusion pump 100 when used in the configuration of
The controller 310 may include a main controller such as a dual core 32-bit processor from NXP of Eindhoven, Netherlands (e.g., model #MCIMX7S5EVM08SC), a microcontroller from NXP (e.g., model #MKV11Z128VLF7), a pump motor driver from ST Microelectronics of Geneva, Switzerland (e.g., model #STSPIN250), and a magnetic encoder from Austriamicrosystems of Premstaetten, Austria (e.g., model number AS5601-ASOM). The microcontroller receives pump cam shaft revolutions per minute (RPM) corresponding to the infusion rate from a System Control Core of the main processor. The microcontroller develops a pulse width modulation (PWM) motor drive parameter relating to the desired cam shaft RPM. The PWM output of the microcontroller becomes the motor drive input to the pump motor driver, which contains motor drive transistors and protection circuitry. The rotation of the cam shaft 306 of the pumping mechanism is measured by the magnetic encoder. At specified time intervals, the output of the encoder is read by the microcontroller, which uses the encoder value to compute the speed of the cam shaft 306 and the position of the pump rotation. These values are then used to modify the PWM output to maintain the correct cam shaft RPM.
While specifically adapted for use outside of a bedside setting, the ambulatory infusion pump 100 may also be used in a bedside setting. In such a case, the ambulatory infusion pump 100 may be connected to tubing (e.g., tubing 108,
As further illustrated in
The lockbox 600 thus includes a housing having first portion 620 and second portion 630 sized and configured to respectively receive a fluid bag 610 or syringe (not shown) and an ambulatory infusion pump 100.
The lockbox 600 described herein thus provides a support for an ambulatory infusion pump 100 for pumping fluid from a fluid bag 610 to a patient in a bedside configuration. The lockbox 600 limits access to the ambulatory infusion pump 100 and the infusate in the fluid bag 610 except by authorized medical personnel who have the key 695 to the screw lock 690 and/or a key to the lock 685. Also, the L-shaped configuration of the lockbox 600 distributes weight around the circumference of the pole 675, when mounted, to provide better stability while maintaining security.
While the foregoing has described what are considered to be the best mode and/or other examples, it is understood that various modifications may be made therein and that the subject matter disclosed herein may be implemented in various forms and examples, and that the teachings may be applied in numerous applications, only some of which have been described herein. It is intended by the following claims to claim any and all applications, modifications and variations that fall within the true scope of the present teachings.
Unless otherwise stated, all measurements, values, ratings, positions, magnitudes, sizes, and other specifications that are set forth in this specification, including in the claims that follow, are approximate, not exact. They are intended to have a reasonable range that is consistent with the functions to which they relate and with what is ordinary in the art to which they pertain.
The scope of protection is limited solely by the claims that now follow. That scope is intended and should be interpreted to be as broad as is consistent with the ordinary meaning of the language that is used in the claims when interpreted in light of this specification and the prosecution history that follows and to encompass all structural and functional equivalents. Notwithstanding, none of the claims are intended to embrace subject matter that fails to satisfy the requirement of Sections 101, 102, or 105 of the Patent Act, nor should they be interpreted in such a way. Any unintended embracement of such subject matter is hereby disclaimed.
Except as stated immediately above, nothing that has been stated or illustrated is intended or should be interpreted to cause a dedication of any component, step, feature, object, benefit, advantage, or equivalent to the public, regardless of whether it is or is not recited in the claims.
It will be understood that the terms and expressions used herein have the ordinary meaning as is accorded to such terms and expressions with respect to their corresponding respective areas of inquiry and study except where specific meanings have otherwise been set forth herein. Relational terms such as first and second and the like may be used solely to distinguish one entity or action from another without necessarily requiring or implying any actual such relationship or order between such entities or actions. The terms “comprises,” “comprising,” “includes,” “including,” or any other variation thereof, are intended to cover a non-exclusive inclusion, such that a process, method, article, or apparatus that includes a list of elements does not include only those elements but may include other elements not expressly listed or inherent to such process, method, article, or apparatus. An element preceded by “a” or “an” does not, without further constraints, preclude the existence of additional identical elements in the process, method, article, or apparatus that includes the element.
The Abstract of the Disclosure is provided to allow the reader to quickly ascertain the nature of the technical disclosure. It is submitted with the understanding that it will not be used to interpret or limit the scope or meaning of the claims. In addition, in the foregoing Detailed Description, it can be seen that various features are grouped together in various embodiments for the purpose of streamlining the disclosure. This method of disclosure is not to be interpreted as reflecting an intention that the claimed embodiments require more features than are expressly recited in each claim. Rather, as the following claims reflect, inventive subject matter lies in less than all features of a single disclosed embodiment. Thus, the following claims are hereby incorporated into the Detailed Description, with each claim standing on its own as a separately claimed subject matter.
In addition, in the foregoing Detailed Description, it can be seen that various features are grouped together in various examples for the purpose of streamlining the disclosure. This method of disclosure is not to be interpreted as reflecting an intention that the claimed examples require more features than are expressly recited in each claim. Rather, as the following claims reflect, the subject matter to be protected lies in less than all features of any single disclosed example. Thus, the following claims are hereby incorporated into the Detailed Description, with each claim standing on its own as a separately claimed subject matter.
While the foregoing describes what is considered to be the best mode and other examples, it is understood that various modifications may be made and that the subject matter disclosed herein may be implemented in various forms and examples, and that they may be applied in numerous applications, only some of which have been described herein. It is intended by the following claims to claim any and all modifications and variations that fall within the true scope of the present concepts.